What is it about?
The biological causes of COPD are likely to be different in different subsets of people with the disease. Advancements in the treatment of COPD may require us to identify these biologically similar subsets, also called “endotypes”, using biomarkers, and to target specific biological therapies to each subset.
Featured Image
Read the Original
This page is a summary of: Targeting Chronic Obstructive Pulmonary Disease Phenotypes, Endotypes, and Biomarkers, Annals of the American Thoracic Society, December 2018, American Thoracic Society,
DOI: 10.1513/annalsats.201808-533mg.
You can read the full text:
Contributors
Be the first to contribute to this page







